- 1-Heterogeneous Resistance to Quizartinib in Acute Myeloid Leukemia ( AML ) Revealed by Single Cell Analysis Short Title : Heterogeneous Resistance to Quizartinib in AML

Catherine C. Smith,Amy Paguirigan,Grace R. Jeschke,Kimberly C. Lin,Evan Massi,Theodore Tarver,Chen-Shan Chin,Saurabh Asthana,Adam Olshen,Kevin J. Travers,Susana Wang,Mark J. Levis,Alexander E. Perl,Jerald P. Radich,Neil P. Shah

semanticscholar（2017）

Cited 0|Views2

No score

Abstract

Division of Hematology/Oncology, University of California, San Francisco, California Fred Hutchinson Cancer Research Center, Seattle, Washington Division of Hematology/Oncology, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania Pacific Biosciences, Menlo Park, California Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California Department of Epidemiology and Biostatistics, University of California, San Francisco, California K.J.T. present affiliation: Roche Sequencing Solutions, Santa Clara, California. S.W. present affiliation: 10X Genomics, San Francisco, California.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined